Pacira Pharms Inc Drug Patent Portfolio

Pacira Pharms Inc owns 4 orange book drugs protected by 30 US patents Given below is the list of Pacira Pharms Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11918565 Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions 02 Feb, 2043
Active
US11931459 Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions 17 Mar, 2042
Active
US11033495 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
Active
US11179336 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
Active
US11278494 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
Active
US11304904 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
Active
US11311486 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
Active
US11357727 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
Active
US11426348 Compositions of bupivacaine multivesicular liposomes 22 Jan, 2041
Active
US11452691 Compositions of bupivacaine multivesicular liposomes 22 Jan, 2041
Active
US11819574 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
Active
US11819575 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
Active
US11925706 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
Active
US8828440 Corticosteroids for the treatment of joint pain 04 Aug, 2031
Active
US9555048 Corticosteroids for the treatment of joint pain 04 Aug, 2031
Active
US9585838 Production of multivesicular liposomes 24 Dec, 2021 Expired
US8182835 Sustained-release liposomal anesthetic compositions 18 Sep, 2018 Expired
US8834921 Sustained-release liposomal anesthetic compositions 18 Sep, 2018 Expired
US9205052 Sustained-release liposomal anesthetic compositions 18 Sep, 2018 Expired
US5891467 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes 31 Jan, 2017 Expired
US5962016 Multivesicular liposomes utilizing neutral lipids to modify in vivo release 31 Jan, 2017 Expired
US6171613 Method for producing liposomes with increased percent of compound encapsulated 01 Oct, 2016 Expired
US5997899 Method for producing liposomes with increased percent of compound encapsulated 01 Sep, 2016 Expired
US6193998 Method for producing liposomes with increased percent of compound encapsulated 01 Sep, 2016 Expired
US6241999 Method for producing liposomes with increased percent of compound encapsulated 01 Sep, 2016 Expired
US5807572 Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride 15 Sep, 2015 Expired
US5931809 Epidural administration of therapeutic compounds with sustained rate of release 14 Jul, 2015 Expired
US5723147 Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride 03 Mar, 2015 Expired
US6132766 Multivesicular liposomes with controlled release of encapsulated biologically active substances 16 Nov, 2013 Expired
US5455044 Method for treating neurological disorders 14 May, 2013 Expired


Given below is the list of recent legal activities going on the following drug patents of Pacira Pharms Inc.

Activity Date Patent Number
Patent litigations
Patent eCofC Notification 02 Jul, 2024 US11819575
Email Notification 02 Jul, 2024 US11819575
Mail Patent eCofC Notification 02 Jul, 2024 US11819575
Recordation of Patent eCertificate of Correction 02 Jul, 2024 US11819575
Post Issue Communication - Certificate of Correction 14 Jun, 2024 US11819575
Email Notification 14 Jun, 2024 US11819575
Mail Certificate of Correction Memo 13 Jun, 2024 US11819575
Certificate of Correction Memo 11 Jun, 2024 US11819575
Electronic Review 07 Jun, 2024 US11931459
Mail Certificate of Correction Memo 08 May, 2024 US11931459
Certificate of Correction Memo 06 May, 2024 US11931459
Email Notification 01 May, 2024 US11918565
Email Notification 30 Apr, 2024 US11918565
Mail Patent eCofC Notification 30 Apr, 2024 US11918565
Patent eCofC Notification 30 Apr, 2024 US11918565


Pacira Pharms Inc's Family Patents

Pacira Pharms Inc drugs have patent protection in a total of 23 countries. It's US patent count contributes only to 35.7% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Pacira Pharms Inc Drug List

Given below is the complete list of Pacira Pharms Inc's drugs and the patents protecting them.


1. Depocyt

Depocyt is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5723147 Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride 03 Mar, 2015
(9 years ago)
Expired
US5455044 Method for treating neurological disorders 14 May, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Depocyt's drug page


2. Depodur

Depodur is protected by 9 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5891467 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes 31 Jan, 2017
(7 years ago)
Expired
US5962016 Multivesicular liposomes utilizing neutral lipids to modify in vivo release 31 Jan, 2017
(7 years ago)
Expired
US6171613 Method for producing liposomes with increased percent of compound encapsulated 01 Oct, 2016
(8 years ago)
Expired
US5997899 Method for producing liposomes with increased percent of compound encapsulated 01 Sep, 2016
(8 years ago)
Expired
US6193998 Method for producing liposomes with increased percent of compound encapsulated 01 Sep, 2016
(8 years ago)
Expired
US6241999 Method for producing liposomes with increased percent of compound encapsulated 01 Sep, 2016
(8 years ago)
Expired
US5807572 Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride 15 Sep, 2015
(9 years ago)
Expired
US5931809 Epidural administration of therapeutic compounds with sustained rate of release 14 Jul, 2015
(9 years ago)
Expired
US5723147 Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride 03 Mar, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Depodur's drug page


3. Exparel

Exparel is protected by 18 patents, out of which 5 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11918565 Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions 02 Feb, 2043
(18 years from now)
Active
US11931459 Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions 17 Mar, 2042
(17 years from now)
Active
US11033495 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
(16 years from now)
Active
US11179336 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
(16 years from now)
Active
US11278494 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
(16 years from now)
Active
US11304904 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
(16 years from now)
Active
US11311486 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
(16 years from now)
Active
US11357727 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
(16 years from now)
Active
US11426348 Compositions of bupivacaine multivesicular liposomes 22 Jan, 2041
(16 years from now)
Active
US11452691 Compositions of bupivacaine multivesicular liposomes 22 Jan, 2041
(16 years from now)
Active
US11819574 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
(16 years from now)
Active
US11819575 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
(16 years from now)
Active
US11925706 Manufacturing of bupivacaine multivesicular liposomes 22 Jan, 2041
(16 years from now)
Active
US9585838 Production of multivesicular liposomes 24 Dec, 2021
(2 years ago)
Expired
US8182835 Sustained-release liposomal anesthetic compositions 18 Sep, 2018
(6 years ago)
Expired
US8834921 Sustained-release liposomal anesthetic compositions 18 Sep, 2018
(6 years ago)
Expired
US9205052 Sustained-release liposomal anesthetic compositions 18 Sep, 2018
(6 years ago)
Expired
US6132766 Multivesicular liposomes with controlled release of encapsulated biologically active substances 16 Nov, 2013
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Exparel's drug page


4. Zilretta

Zilretta is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8828440 Corticosteroids for the treatment of joint pain 04 Aug, 2031
(6 years from now)
Active
US9555048 Corticosteroids for the treatment of joint pain 04 Aug, 2031
(6 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zilretta's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List